Table 2.
Type of Delivery System | Composition | Major Outcome | Ref |
---|---|---|---|
Oral Administration | |||
Solid lipid nanoparticles | Precirol ATO 5 Tween 80 |
gastric and intestinal cells tolerate more CLZ when loaded in the nanoparticles than free in solution | [84] |
Polymeric nanoparticles | PLGA | nanoparticles decreased drug intrinsic toxicity, with improved intestinal permeation | [85] |
Transdermal administration | |||
Liposomes | Phosphatidylcholine Cholesterol HPMC (matrix to deliver liposomes) |
liposomal gels were found to be stable at room temperature for up to 3 months | [86] |
Other applications | |||
Solid dispersions | Hypromellose phthalate Hypromellose vinylpyrrolidone-vinyl acetate |
elucidation of a possible structural model of the drug–polymer complex | [87] |
Solid dispersions | Hypromellose phthalate Hypromellose vinylpyrrolidone-vinyl acetate |
contribution to a rational selection of appropriate polymeric carriers | [88] |